{"id":"https://openalex.org/W4415788914","doi":"https://doi.org/10.1158/2159-8290.c.8126007","title":"Data from Decoding the Genomic and Functional Landscape of Emerging Subtypes in Ovarian Cancer","display_name":"Data from Decoding the Genomic and Functional Landscape of Emerging Subtypes in Ovarian Cancer","publication_year":2025,"publication_date":"2025-11-03","ids":{"openalex":"https://openalex.org/W4415788914","doi":"https://doi.org/10.1158/2159-8290.c.8126007"},"language":"en","primary_location":{"id":"doi:10.1158/2159-8290.c.8126007","doi":"https://doi.org/10.1158/2159-8290.c.8126007","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2159-8290.c.8126007","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/2159-8290.c.8126007","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037859769","display_name":"Giulia Micoli","orcid":"https://orcid.org/0009-0003-9541-8177","observed_orcids":["https://orcid.org/0009-0003-9541-8177"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Giulia Micoli","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0003-9541-8177","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031949650","display_name":"Kari Lavikka","orcid":"https://orcid.org/0000-0002-4163-4945","observed_orcids":["https://orcid.org/0000-0002-4163-4945"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kari Lavikka","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4163-4945","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088007433","display_name":"Yilin Li","orcid":"https://orcid.org/0000-0002-3268-1969","observed_orcids":["https://orcid.org/0000-0002-3268-1969"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yilin Li","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3268-1969","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093975375","display_name":"Anna Pirttikoski","orcid":"https://orcid.org/0009-0007-8825-8004","observed_orcids":["https://orcid.org/0009-0007-8825-8004"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna Pirttikoski","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0007-8825-8004","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006337168","display_name":"Daria Afenteva","orcid":"https://orcid.org/0009-0000-9596-2832","observed_orcids":["https://orcid.org/0009-0000-9596-2832"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daria Afenteva","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0000-9596-2832","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013696600","display_name":"Wojciech Senkowski","orcid":"https://orcid.org/0000-0001-8120-1944","observed_orcids":["https://orcid.org/0000-0001-8120-1944"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wojciech Senkowski","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8120-1944","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057654083","display_name":"Giovanni Marchi","orcid":"https://orcid.org/0000-0001-9513-1123","observed_orcids":["https://orcid.org/0000-0001-9513-1123"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Giovanni Marchi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9513-1123","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076351886","display_name":"Anna V\u00e4h\u00e4rautio","orcid":"https://orcid.org/0000-0003-4721-3954","observed_orcids":["https://orcid.org/0000-0003-4721-3954"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna V\u00e4h\u00e4rautio","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4721-3954","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100332144","display_name":"Taru Muranen","orcid":"https://orcid.org/0000-0002-5895-1808","observed_orcids":["https://orcid.org/0000-0002-5895-1808"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Taru A. Muranen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5895-1808","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091615132","display_name":"Titta Joutsiniemi","orcid":"https://orcid.org/0000-0003-2169-9933","observed_orcids":["https://orcid.org/0000-0003-2169-9933"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Titta Joutsiniemi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2169-9933","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081022486","display_name":"Sakari Hietanen","orcid":"https://orcid.org/0000-0003-4734-4743","observed_orcids":["https://orcid.org/0000-0003-4734-4743"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sakari Hietanen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4734-4743","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067676296","display_name":"Anni Virtanen","orcid":"https://orcid.org/0000-0002-7467-8434","observed_orcids":["https://orcid.org/0000-0002-7467-8434"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anni Virtanen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7467-8434","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067760174","display_name":"Krister Wennerberg","orcid":"https://orcid.org/0000-0002-1352-4220","observed_orcids":["https://orcid.org/0000-0002-1352-4220"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Krister Wennerberg","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1352-4220","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044104350","display_name":"Johanna Hynninen","orcid":"https://orcid.org/0000-0002-0854-7225","observed_orcids":["https://orcid.org/0000-0002-0854-7225"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Johanna Hynninen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0854-7225","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075672043","display_name":"Jaana Oikkonen","orcid":"https://orcid.org/0000-0002-1063-2736","observed_orcids":["https://orcid.org/0000-0002-1063-2736"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jaana Oikkonen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1063-2736","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5033102814","display_name":"Sampsa Hautaniemi","orcid":"https://orcid.org/0000-0002-7749-2694","observed_orcids":["https://orcid.org/0000-0002-7749-2694"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sampsa Hautaniemi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7749-2694","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9477999806404114,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9477999806404114,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.03840000182390213,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.008200000040233135,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/high-grade-serous-ovarian-carcinoma","display_name":"high-grade serous ovarian cancer","score":0.9419999718666077},{"id":"https://openalex.org/keywords/tumor-subtypes","display_name":"tumor subtypes","score":0.9150000214576721},{"id":"https://openalex.org/keywords/homologous-recombination-deficiency","display_name":"homologous recombination deficiency","score":0.9520000219345093},{"id":"https://openalex.org/keywords/chromosomal-instability","display_name":"chromosomal instability","score":0.7210000157356262},{"id":"https://openalex.org/keywords/structural-variants","display_name":"structural variants","score":0.9010000228881836},{"id":"https://openalex.org/keywords/brca1","display_name":"BRCA1","score":0.7210000157356262},{"id":"https://openalex.org/keywords/brca2","display_name":"BRCA2","score":0.9990000128746033},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.7879999876022339},{"id":"https://openalex.org/keywords/platinum-based-chemotherapy","display_name":"platinum-based chemotherapy","score":0.6919999718666077},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.7910000085830688},{"id":"https://openalex.org/keywords/chk1-inhibition","display_name":"CHK1 inhibition","score":0.6990000009536743},{"id":"https://openalex.org/keywords/prexasertib","display_name":"prexasertib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/organoids","display_name":"organoids","score":0.5989999771118164},{"id":"https://openalex.org/keywords/genomic-instability","display_name":"genomic instability","score":0.44600000977516174},{"id":"https://openalex.org/keywords/intratumor-heterogeneity","display_name":"intratumoral heterogeneity","score":0.6520000100135803}],"concepts":[{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6136999726295471},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.6061999797821045},{"id":"https://openalex.org/C178169997","wikidata":"https://www.wikidata.org/wiki/Q2892636","display_name":"Genome instability","level":4,"score":0.5841000080108643},{"id":"https://openalex.org/C3019054536","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian carcinoma","level":4,"score":0.5598999857902527},{"id":"https://openalex.org/C124942203","wikidata":"https://www.wikidata.org/wiki/Q656638","display_name":"Comparative genomic hybridization","level":4,"score":0.4860999882221222},{"id":"https://openalex.org/C102744134","wikidata":"https://www.wikidata.org/wiki/Q22280388","display_name":"Homologous recombination","level":3,"score":0.45980000495910645},{"id":"https://openalex.org/C163763905","wikidata":"https://www.wikidata.org/wiki/Q17075943","display_name":"Precision medicine","level":2,"score":0.44780001044273376},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4442000091075897},{"id":"https://openalex.org/C32220436","wikidata":"https://www.wikidata.org/wiki/Q2072214","display_name":"Personalized medicine","level":2,"score":0.42480000853538513},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.40380001068115234},{"id":"https://openalex.org/C140752955","wikidata":"https://www.wikidata.org/wiki/Q1087752","display_name":"Chromosome instability","level":4,"score":0.3984000086784363},{"id":"https://openalex.org/C98108389","wikidata":"https://www.wikidata.org/wiki/Q412563","display_name":"CRISPR","level":3,"score":0.3961000144481659},{"id":"https://openalex.org/C150173356","wikidata":"https://www.wikidata.org/wiki/Q6144101","display_name":"Serous fluid","level":2,"score":0.3903000056743622},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.375},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.37439998984336853},{"id":"https://openalex.org/C2777632260","wikidata":"https://www.wikidata.org/wiki/Q19000698","display_name":"Serous carcinoma","level":4,"score":0.3698999881744385},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3549000024795532},{"id":"https://openalex.org/C189206191","wikidata":"https://www.wikidata.org/wiki/Q222046","display_name":"Genomics","level":4,"score":0.3540000021457672},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3431999981403351},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.33880001306533813},{"id":"https://openalex.org/C31695470","wikidata":"https://www.wikidata.org/wiki/Q11293125","display_name":"Organoid","level":2,"score":0.3278999924659729},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.30720001459121704},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.2987000048160553},{"id":"https://openalex.org/C162317418","wikidata":"https://www.wikidata.org/wiki/Q252857","display_name":"Transcriptome","level":4,"score":0.2709999978542328},{"id":"https://openalex.org/C120821319","wikidata":"https://www.wikidata.org/wiki/Q1501491","display_name":"Copy-number variation","level":4,"score":0.2700999975204468},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.27000001072883606},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.2678000032901764},{"id":"https://openalex.org/C2778502085","wikidata":"https://www.wikidata.org/wiki/Q7662767","display_name":"Synthetic lethality","level":4,"score":0.2676999866962433},{"id":"https://openalex.org/C3019816032","wikidata":"https://www.wikidata.org/wiki/Q2575340","display_name":"Cancer treatment","level":3,"score":0.26739999651908875},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.26600000262260437},{"id":"https://openalex.org/C141231307","wikidata":"https://www.wikidata.org/wiki/Q7020","display_name":"Genome","level":3,"score":0.2621000111103058},{"id":"https://openalex.org/C47042493","wikidata":"https://www.wikidata.org/wiki/Q265799","display_name":"Human genetics","level":3,"score":0.260699987411499},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2531000077724457}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2159-8290.c.8126007","doi":"https://doi.org/10.1158/2159-8290.c.8126007","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2159-8290.c.8126007","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/2159-8290.c.8126007","doi":"https://doi.org/10.1158/2159-8290.c.8126007","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2159-8290.c.8126007","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4412756429","https://openalex.org/W4362541145","https://openalex.org/W2408848642","https://openalex.org/W4399331132","https://openalex.org/W6922157748","https://openalex.org/W4392367454","https://openalex.org/W2072718413","https://openalex.org/W2560002078","https://openalex.org/W4415786958","https://openalex.org/W3081803265"],"abstract_inverted_index":{"Abstract":[0],"Ovarian":[1],"high-grade":[2],"serous":[3],"carcinoma":[4],"(HGSC)":[5],"is":[6],"characterized":[7,59,77],"by":[8,111],"pervasive":[9],"genomic":[10,61],"instability":[11,74],"and":[12,15,34,53,82,115,122,160,173],"high":[13],"inter-":[14],"intra-tumor":[16],"heterogeneity.":[17],"Approximately":[18],"half":[19],"of":[20,63,171],"HGSC":[21,56,85,153,172],"tumors":[22,65,154],"harbor":[23],"homologous":[24],"recombination":[25],"deficiency":[26],"(HRD),":[27],"rendering":[28],"them":[29],"vulnerable":[30],"to":[31,47,132,177],"PARP":[32],"inhibitors":[33],"platinum-based":[35],"chemotherapy.":[36],"In":[37],"contrast,":[38],"patients":[39,68],"lacking":[40],"HRD":[41,93],"(HR-proficient,":[42],"HRP)":[43],"generally":[44],"respond":[45],"poorly":[46],"current":[48],"therapies.":[49],"To":[50],"overcome":[51],"heterogeneity":[52],"identify":[54],"relevant":[55],"subtypes,":[57,86,94,163],"we":[58],"the":[60,78,168],"landscape":[62,81],"640":[64],"from":[66],"243":[67],"using":[69],"whole-genome":[70],"sequencing.":[71],"Our":[72],"chromosomal":[73],"signature\u2013based":[75],"analysis":[76],"structural":[79,113],"variation":[80],"revealed":[83],"five":[84],"validated":[87],"in":[88],"an":[89],"independent":[90],"dataset.":[91],"Two":[92],"associated":[95],"with":[96],"BRCA1-":[97],"or":[98],"BRCA2-driven":[99],"alterations,":[100],"demonstrated":[101],"favorable":[102],"treatment":[103,141],"responses.":[104,125],"Strikingly,":[105],"three":[106],"HRP":[107,146,183],"subtypes":[108],"emerged,":[109],"marked":[110],"unique":[112],"alterations":[114],"gene":[116],"expression":[117],"patterns,":[118],"tumor":[119],"microenvironment":[120],"interactions,":[121],"different":[123],"chemotherapy":[124],"Notably,":[126],"organoid":[127],"experiments":[128],"showed":[129],"subtype-specific":[130],"sensitivity":[131],"CHK1":[133],"inhibition,":[134],"suggesting":[135],"prexasertib":[136],"as":[137],"a":[138,175],"potential":[139],"targeted":[140],"for":[142,182],"most":[143],"currently":[144,186],"untreatable":[145],"patients.":[147],"Significance:":[148],"These":[149],"findings":[150],"demonstrate":[151],"that":[152],"can":[155],"be":[156],"divided":[157],"into":[158,167],"functionally":[159],"clinically":[161],"distinct":[162],"offering":[164],"new":[165],"insights":[166],"underlying":[169],"biology":[170],"providing":[174],"foundation":[176],"develop":[178],"tailored":[179],"therapeutic":[180],"strategies":[181],"tumors,":[184],"which":[185],"lack":[187],"effective":[188],"options.":[189]},"counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2025-11-03T00:00:00"}
